These findings are consistent with the in vitro results and indicate that CHD1L can promote the invasion and metastasis of breast cancer by promoting the PI3K/Akt/ARK5/mTOR/MMP signaling pathway. This evidence concerns the gene NUAK1 and breast carcinoma.